Correlation Between Standard Biotools and Pacific Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Standard Biotools and Pacific Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Standard Biotools and Pacific Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Standard Biotools and Pacific Biosciences of, you can compare the effects of market volatilities on Standard Biotools and Pacific Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Standard Biotools with a short position of Pacific Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Standard Biotools and Pacific Biosciences.

Diversification Opportunities for Standard Biotools and Pacific Biosciences

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between Standard and Pacific is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Standard Biotools and Pacific Biosciences of in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacific Biosciences and Standard Biotools is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Standard Biotools are associated (or correlated) with Pacific Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacific Biosciences has no effect on the direction of Standard Biotools i.e., Standard Biotools and Pacific Biosciences go up and down completely randomly.

Pair Corralation between Standard Biotools and Pacific Biosciences

Considering the 90-day investment horizon Standard Biotools is expected to under-perform the Pacific Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Standard Biotools is 1.69 times less risky than Pacific Biosciences. The stock trades about -0.03 of its potential returns per unit of risk. The Pacific Biosciences of is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  128.00  in Pacific Biosciences of on August 13, 2025 and sell it today you would earn a total of  48.00  from holding Pacific Biosciences of or generate 37.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Standard Biotools  vs.  Pacific Biosciences of

 Performance 
       Timeline  
Standard Biotools 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Standard Biotools has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Pacific Biosciences 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pacific Biosciences of are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain fundamental indicators, Pacific Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Standard Biotools and Pacific Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Standard Biotools and Pacific Biosciences

The main advantage of trading using opposite Standard Biotools and Pacific Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Standard Biotools position performs unexpectedly, Pacific Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacific Biosciences will offset losses from the drop in Pacific Biosciences' long position.
The idea behind Standard Biotools and Pacific Biosciences of pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios